Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0000897069-25-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-01-29 | 2025-01-27 | PCSA | Ng George K | CEO, Dir | P - Purchase | $0.8 | +87.2K | 87.2K | New | +$69.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-27 | P | A | 87,200 | $0.8 | 87,200 | I George Ng IRRA FBO: George Ng | — | — |